Cargando…
Effect of Androgen Blockade on HER-2 and Matrix Metalloproteinase-2 Expression on Bone Marrow Micrometastasis and Stromal Cells in Men with Prostate Cancer
Introduction. HER-2 has been associated with castrate resistant prostate cancer and matrix metalloproteinase-2 (MMP-2) in the dissemination and invasion of tumor cells as well as activating angiogenesis. We present an immunocytochemical study of the effect of androgen blockade on the expression of H...
Autores principales: | Murray, N. P., Reyes, E., Badinez, L., Orellana, N., Fuentealba, C., Olivares, R., Porcell, J., Dueñas, R. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Hindawi Publishing Corporation
2013
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3666220/ https://www.ncbi.nlm.nih.gov/pubmed/23766685 http://dx.doi.org/10.1155/2013/281291 |
Ejemplares similares
-
Differential Expression of Matrix Metalloproteinase-2 Expression in Disseminated Tumor Cells and Micrometastasis in Bone Marrow of Patients with Nonmetastatic and Metastatic Prostate Cancer: Theoretical Considerations and Clinical Implications—An Immunocytochemical Study
por: Murray, Nigel P., et al.
Publicado: (2012) -
Secondary Circulating Prostate Cells Predict Biochemical Failure in Prostate Cancer Patients after Radical Prostatectomy and without Evidence of Disease
por: Murray, Nigel P., et al.
Publicado: (2013) -
Circulating Prostate Cells Found in Men with Benign Prostate Disease Are P504S Negative: Clinical Implications
por: Murray, Nigel P., et al.
Publicado: (2013) -
Positive HER-2 protein expression in circulating prostate cells and micro-metastasis, resistant to androgen blockage but not diethylstilbestrol
por: Murray, Nigel P., et al.
Publicado: (2011) -
HER2 status of bone marrow micrometastasis and their corresponding primary tumours in a pilot study of 27 cases: a possible tool for anti-HER2 therapy management?
por: Vincent-Salomon, A, et al.
Publicado: (2007)